AMED - Richard Ashworth Exercises Options Realizes $171K | Benzinga
Richard Ashworth, President and CEO at Amedisys (NASDAQ:AMED), reported a large exercise of company stock options on December 28, according to a new SEC filing.
What Happened: Ashworth, President and CEO at Amedisys, made a strategic move by exercising stock options for 11,237 shares of AMED as detailed in a Form 4 filing on Thursday with the U.S. Securities and Exchange Commission. The transaction value amounted to $171,027.
Amedisys shares are trading down 0.0% at $95.04 at the time of this writing on Friday morning. Since the current price is $95.04, this makes Ashworth's 11,237 shares worth $171,027.
Get to Know Amedisys Better
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived ...